Factors associated with medication adherence trajectory among patients treated with oral anticancer drugs: a multicentre cohort study
Authors:
- Germain PerrinGPGermain Perrin
- Audrey Thomas-SchoemannATAudrey Thomas-Schoemann
- François GoldwasserFGFrançois Goldwasser
- Pascaline Boudou-RouquettePBPascaline Boudou-Rouquette
- Nicolas DelanoyNDNicolas Delanoy
- Claire GervaisCGClaire Gervais
- Justine TouchardJTJustine Touchard
- Rui BatistaRui Batista
- Benoit BlanchetBenoit Blanchet
- Jean-Stéphane GiraudJGJean-Stéphane Giraud
- Brigitte SabatierBSBrigitte Sabatier
- Virginie Korb-SavoldelliVKVirginie Korb-Savoldelli
Open Access
- 15 October 2025
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (11) , 1-15
Abstract
Purpose Optimal medication adherence to oral systemic anticancer therapies (SACTs) is critical for effective cancer management. However, the factors influencing adherence, particularly in relation to the longitudinal course of the disease, remain poorly understood. This study aimed to identify factors associated with medication adherence trajectories among patients initiating oral SACTs. Methods A multicentre cohort study was conducted among patients initiating oral SACTs and enrolled in a multidisciplinary risk management programme during day hospitalisation. Medication adherence trajectories were identified using group-based trajectory modelling (GBTM), based on scores from a validated six-item medication adherence questionnaire. Factors associated with trajectory allocation were examined using bias-reduced multinomial logistic regression. Results A total of 135 participants were included, of whom 71 provided at least two adherence scores for trajectory modelling. Three latent groups of adherence trajectories were identified: (i) continuous optimal adherence (73.2%), (ii) improving adherence (9.9%), and (iii) declining adherence (16.9%). In multivariate analysis, subjects belonging to the declining adherence group were more likely to belong to the low-income category. Conclusion GBTM identified three distinct and clinically relevant patterns of oral SACT adherence trajectories among outpatients followed during day hospitalisation. Understanding the factors influencing these trajectories provides a dynamic perspective on the complex phenomenon of medication adherence and highlights actionable factors to support tailored health interventions.Keywords
Funding Information
- Grant “Direction Générale de l’Offre de Soins” for the implementation of clinical pharmacy activities in French hospitals
This publication has 56 references indexed in Scilit:
- Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancerBreast Cancer Research and Treatment, 2010
- Good and poor adherence: optimal cut-point for adherence measures using administrative claims dataCurrent Medical Research and Opinion, 2009
- Patient Autonomy for the Management of Chronic Conditions: A Two-Component Re-ConceptualizationThe American Journal of Bioethics, 2009
- Contrasting Measures of Adherence with Simple Drug Use, Medication Switching, and Therapeutic DuplicationAnnals of Pharmacotherapy, 2009
- “White Coat Compliance” Limits the Reliability of Therapeutic Drug Monitoring in HIV-1—Infected PatientsHIV Research & Clinical Practice, 2008
- Complementary and Alternative Medicine Among Advanced Cancer Patients Enrolled on Phase I Trials: A Study of Prognosis, Quality of Life, and Preferences for Decision MakingJournal of Clinical Oncology, 2007
- Potential health risks of complementary alternative medicines in cancer patientsBritish Journal of Cancer, 2004
- Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast CancerJournal of Clinical Oncology, 2003
- Answering Patients' Needs: Oral Alternatives to Intravenous TherapyThe Oncologist, 2001
- Toxicity and response criteria of the Eastern Cooperative Oncology GroupAmerican Journal of Clinical Oncology, 1982